HPS masthead
What's New?
. Fukushima Decontamination Report
. CRCPD & CDC Grants for Volunteer Corps
. America's Nuclear Future
. February Newsletter
. Boice Nominated President of NCRP
. February Journal
. February ORS
. Schauer Given the Butterfly Award from Image Gently
. Kase President's Report to IRPA
. IRPA13 Accepting Posters
Upcoming Events
. HPS Midyear - Issues in Waste Management
5-8 February 2012
Dallas, Texas
. NRC Regulatory Information Conference
NRC Regulatory Information Conference
13-15 March 2012
Rockville, Maryland
. NCRP Annual Meeting
12-13 March 2012
Washington, DC
. James E. Turner Memorial Symposium
Call for Abstracts
18-19 April 2012
Oak Ridge Associated Universities, Pollard Auditorium, Oak Ridge, Tennessee
. IRPA13
13-18 May 2012
Glasgow, Scotland
. Canadian Radiation Protection Association (CRPA) Annual Meeting
27-30 May 2012
Halifax, Nova Scotia
. ACS Undergrad Summer Schools
10 June- 20 July 2012
. Nuclear Regulatory Commission Meeting Webcasts
February 2012
Bethesda, Maryland
09 February 2012

Answer to Question #8244 Submitted to "Ask the Experts"

Category: Nuclear Medicine Patient Issues

The following question was answered by an expert in the appropriate field:

Q
I had a thyroidectomy and the pathologist report showed a tumor less than 1 cm diameter at the isthmus and two smaller tumors in the left lobe, both less than 0.3 cm in size. No other cancers were found. The recommendation is to follow up with iodine-131 treatments to be sure all cancer cells associated with the thyroid are killed off. The levels of dosage recommended are either 29 millicuries or 75 millicuries, OR take a smaller dosage and scan for any spreading of these cells and take a higher dosage later if necessary. What are the risks of another cancer type from exposure to the iodine-131 treatments? I am a 51-year-old male in good health, but my family history (mother's side) has colon and breast cancer.

A
Fortunately, these doses of iodine-131, and even higher doses, are not associated with the production of any kind of cancer. There was a claim many years ago, that is not well substantiated, that doses over 1,000 millicuries can cause leukemia. Maybe so, but your dose will be much lower than this.

The reason for the "mop-up" dose is mainly to get rid of normal thyroid tissue; small amounts are virtually always left behind after surgery in order to avoid damage to parathyroid arteries and the recurrent laryngeal nerves. Once these normal remnants are gone, you can be followed with a blood test for thyroglobulin, which is made by most differentiated thyroid cancers. (Normal thyroid tissue makes this as well, which makes the test difficult to interpret. That is why you want to get rid of all the normal thyroid tissue.)

I assume that your lymph nodes were negative for thyroid cancer. If that is the case, it is highly unlikely that you have any other thyroid cancer cells around to get rid of, as your cancers were very small. (The person's lymph nodes were negative for thyroid cancer.)

You have an excellent prognosis.

Carol S. Marcus, PhD, MD
Professor of Radiation Oncology and of Radiologic Sciences, UCLA


Answer posted on 9 June 2009. The information and material posted on this website is intended as general reference information only. Specific facts and circumstances may alter the concepts and applications of materials and information described herein. The information provided is not a substitute for professional advice and should not be relied upon in the absence of such professional advice specific to whatever facts and circumstances are presented in any given situation. Answers are correct at the time they are posted on the Website. Be advised that over time, some requirements could change, new data could be made available, or Internet links could change. For answers that have been posted for several months or longer, please check the current status of the posted information prior to using the responses for specific applications.
image
image
Home Affiliates Ask the Experts Radiation Terms Employment Meetings